Literature DB >> 19590728

Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy.

Mi-Kyung Kim1, Jae Weon Kim.   

Abstract

Entities:  

Year:  2009        PMID： 19590728      PMCID： PMC2704997          DOI： 10.3802/jgo.2009.20.2.132

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  7 in total

1.  Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.

Authors:  H H Lin; W F Cheng; K W Chan; D Y Chang; C K Chen; S C Huang
Journal:  Obstet Gynecol       Date:  1996-08       Impact factor: 7.661

2.  The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB.

Authors:  T Inoue; K Morita
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

3.  Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.

Authors:  Chel Hun Choi; Jeong-Won Lee; Tae-Joong Kim; Woo Young Kim; Hee Rim Nam; Byoung-Gie Kim; Seung Jae Huh; Je-Ho Lee; Duk-Soo Bae
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

4.  Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix.

Authors:  J W Lee; B G Kim; S J Lee; S H Lee; C S Park; J H Lee; S J Huh; D S Bae
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

5.  High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.

Authors:  Y Aoki; M Sasaki; M Watanabe; T Sato; I Tsuneki; H Aida; K Tanaka
Journal:  Gynecol Oncol       Date:  2000-05       Impact factor: 5.482

6.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification.

Authors:  Woo-Young Kim; Suk-Joon Chang; Ki-Hong Chang; Seung-Chul Yoo; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.